AAPG Earnings

AAPG reported its earnings on 2026-03-25, showcasing a revenue of against an estimate of 83.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a -4.84% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following AAPG's earnings announcement on 2026-03-25, the stock price moved by -4.84% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, AAPG's stock price tends to shift by an average of -3.04% in the 10 days leading up to earnings and -7.73% in the 10 days following, providing insight into potential market.

For , analysts estimate AAPG's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between AAPG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, AAPG's stock price typically moves by -3.04% in the 10 days before its earnings and -7.73% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call summary indicates strong financial performance with robust enrollment in clinical trials and significant commercial growth opportunities for key products in China. Positive market strategies, such as NRDL coverage and partnerships with Takeda, support growth. The Q&A section highlights analysts' positive sentiment, despite some unclear management responses. Overall, the combination of strong clinical data, market expansion, and strategic partnerships suggests a positive impact on stock price.